PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

Mantle Cell Lymphoma

Mantle cell lymphoma drug access, BTK inhibitor sequencing, BCL-2 inhibitor coverage, CAR-T eligibility, and hematologic oncology payer criteria.

1 article·Lives underPricing & Access Specialty·Last updated 2026-05-28

Approvals· May 28, 2026 · 7 min read

Beqalzi (sonrotoclax) coverage guide: a new BCL-2 inhibitor for relapsed or refractory mantle cell lymphoma

By Ran Chen#Mantle Cell Lymphoma #BCL-2 Inhibitor #Oncology